Logo image of CMSA

CMS ENERGY CORP - CMS 5 5/8 03/15/2078 (CMSA) Stock Fundamental Analysis

USA - NYSE:CMSA - US1258968601

23.451 USD
+0.02 (+0.09%)
Last: 9/16/2025, 8:07:34 PM
Fundamental Rating

5

Overall CMSA gets a fundamental rating of 5 out of 10. We evaluated CMSA against 25 industry peers in the Multi-Utilities industry. CMSA scores excellent on profitability, but there are concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on CMSA.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CMSA had positive earnings in the past year.
In the past year CMSA had a positive cash flow from operations.
In the past 5 years CMSA has always been profitable.
Each year in the past 5 years CMSA had a positive operating cash flow.
CMSA Yearly Net Income VS EBIT VS OCF VS FCFCMSA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

The Return On Assets of CMSA (2.69%) is comparable to the rest of the industry.
CMSA has a better Return On Equity (12.07%) than 80.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.74%, CMSA is in line with its industry, outperforming 52.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CMSA is in line with the industry average of 3.82%.
The last Return On Invested Capital (3.74%) for CMSA is above the 3 year average (3.46%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.69%
ROE 12.07%
ROIC 3.74%
ROA(3y)2.67%
ROA(5y)3.05%
ROE(3y)11.83%
ROE(5y)13.91%
ROIC(3y)3.46%
ROIC(5y)3.6%
CMSA Yearly ROA, ROE, ROICCMSA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

CMSA has a Profit Margin of 12.64%. This is comparable to the rest of the industry: CMSA outperforms 60.00% of its industry peers.
CMSA's Profit Margin has improved in the last couple of years.
CMSA has a Operating Margin of 20.00%. This is comparable to the rest of the industry: CMSA outperforms 48.00% of its industry peers.
CMSA's Operating Margin has improved in the last couple of years.
The Gross Margin of CMSA (71.26%) is better than 68.00% of its industry peers.
CMSA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 20%
PM (TTM) 12.64%
GM 71.26%
OM growth 3Y8.16%
OM growth 5Y1.8%
PM growth 3Y-10.44%
PM growth 5Y5.87%
GM growth 3Y3.22%
GM growth 5Y2.04%
CMSA Yearly Profit, Operating, Gross MarginsCMSA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CMSA is destroying value.
The number of shares outstanding for CMSA has been increased compared to 1 year ago.
The number of shares outstanding for CMSA has been increased compared to 5 years ago.
CMSA has a better debt/assets ratio than last year.
CMSA Yearly Shares OutstandingCMSA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
CMSA Yearly Total Debt VS Total AssetsCMSA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

Based on the Altman-Z score of 0.58, we must say that CMSA is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CMSA (0.58) is worse than 84.00% of its industry peers.
A Debt/Equity ratio of 2.02 is on the high side and indicates that CMSA has dependencies on debt financing.
CMSA's Debt to Equity ratio of 2.02 is on the low side compared to the rest of the industry. CMSA is outperformed by 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.02
Debt/FCF N/A
Altman-Z 0.58
ROIC/WACC0.71
WACC5.24%
CMSA Yearly LT Debt VS Equity VS FCFCMSA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

CMSA has a Current Ratio of 1.00. This is a bad value and indicates that CMSA is not financially healthy enough and could expect problems in meeting its short term obligations.
CMSA has a better Current ratio (1.00) than 80.00% of its industry peers.
CMSA has a Quick Ratio of 1.00. This is a bad value and indicates that CMSA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Quick ratio value of 0.77, CMSA is doing good in the industry, outperforming 80.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 0.77
CMSA Yearly Current Assets VS Current LiabilitesCMSA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

CMSA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.56%.
CMSA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.05% yearly.
CMSA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.25%.
CMSA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.89% yearly.
EPS 1Y (TTM)4.56%
EPS 3Y5.55%
EPS 5Y6.05%
EPS Q2Q%7.58%
Revenue 1Y (TTM)8.25%
Revenue growth 3Y0.84%
Revenue growth 5Y1.89%
Sales Q2Q%14.37%

3.2 Future

The Earnings Per Share is expected to grow by 7.60% on average over the next years.
The Revenue is expected to grow by 4.67% on average over the next years.
EPS Next Y8.4%
EPS Next 2Y7.91%
EPS Next 3Y7.87%
EPS Next 5Y7.6%
Revenue Next Year2.73%
Revenue Next 2Y3.36%
Revenue Next 3Y3.58%
Revenue Next 5Y4.67%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CMSA Yearly Revenue VS EstimatesCMSA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
CMSA Yearly EPS VS EstimatesCMSA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 6.82, which indicates a rather cheap valuation of CMSA.
Based on the Price/Earnings ratio, CMSA is valued cheaply inside the industry as 84.00% of the companies are valued more expensively.
CMSA is valuated cheaply when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
CMSA is valuated cheaply with a Price/Forward Earnings ratio of 6.03.
84.00% of the companies in the same industry are more expensive than CMSA, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CMSA to the average of the S&P500 Index (22.71), we can say CMSA is valued rather cheaply.
Industry RankSector Rank
PE 6.82
Fwd PE 6.03
CMSA Price Earnings VS Forward Price EarningsCMSA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CMSA indicates a somewhat cheap valuation: CMSA is cheaper than 80.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.49
CMSA Per share dataCMSA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CMSA has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.81
PEG (5Y)1.13
EPS Next 2Y7.91%
EPS Next 3Y7.87%

4

5. Dividend

5.1 Amount

CMSA has a Yearly Dividend Yield of 3.03%.
With a Dividend Yield of 3.03, CMSA pays less dividend than the industry average, which is at 3.64. 84.00% of the companies listed in the same industry pay a better dividend than CMSA!
CMSA's Dividend Yield is a higher than the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 3.03%

5.2 History

The dividend of CMSA is nicely growing with an annual growth rate of 6.54%!
CMSA has been paying a dividend for over 5 years, so it has already some track record.
CMSA has decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.54%
Div Incr Years0
Div Non Decr Years2
CMSA Yearly Dividends per shareCMSA Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

CMSA pays out 71.96% of its income as dividend. This is not a sustainable payout ratio.
CMSA's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP71.96%
EPS Next 2Y7.91%
EPS Next 3Y7.87%
CMSA Yearly Income VS Free CF VS DividendCMSA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B
CMSA Dividend Payout.CMSA Dividend Payout, showing the Payout Ratio.CMSA Dividend Payout.PayoutRetained Earnings

CMS ENERGY CORP - CMS 5 5/8 03/15/2078

NYSE:CMSA (9/16/2025, 8:07:34 PM)

23.451

+0.02 (+0.09%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-29 2025-10-29/amc
Inst Owners98.16%
Inst Owner ChangeN/A
Ins Owners0.56%
Ins Owner ChangeN/A
Market Cap7.02B
Analysts75.24
Price Target25.4 (8.31%)
Short Float %0%
Short Ratio0.32
Dividend
Industry RankSector Rank
Dividend Yield 3.03%
Yearly Dividend2.11
Dividend Growth(5Y)6.54%
DP71.96%
Div Incr Years0
Div Non Decr Years2
Ex-Date08-29 2025-08-29 (0.3515625)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.85%
Min EPS beat(2)-0.41%
Max EPS beat(2)2.11%
EPS beat(4)2
Avg EPS beat(4)1.89%
Min EPS beat(4)-1.09%
Max EPS beat(4)6.96%
EPS beat(8)4
Avg EPS beat(8)1.62%
EPS beat(12)7
Avg EPS beat(12)5.35%
EPS beat(16)10
Avg EPS beat(16)5.04%
Revenue beat(2)2
Avg Revenue beat(2)6.5%
Min Revenue beat(2)4.73%
Max Revenue beat(2)8.27%
Revenue beat(4)2
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-11.28%
Max Revenue beat(4)8.27%
Revenue beat(8)2
Avg Revenue beat(8)-9.38%
Revenue beat(12)5
Avg Revenue beat(12)-3.72%
Revenue beat(16)9
Avg Revenue beat(16)0.52%
PT rev (1m)8.78%
PT rev (3m)11.4%
EPS NQ rev (1m)-1.62%
EPS NQ rev (3m)-3.57%
EPS NY rev (1m)-0.03%
EPS NY rev (3m)-0.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.26%
Revenue NY rev (1m)1.04%
Revenue NY rev (3m)1.4%
Valuation
Industry RankSector Rank
PE 6.82
Fwd PE 6.03
P/S 0.88
P/FCF N/A
P/OCF 3.21
P/B 0.84
P/tB 0.84
EV/EBITDA 8.49
EPS(TTM)3.44
EY14.67%
EPS(NY)3.89
Fwd EY16.59%
FCF(TTM)-3.53
FCFYN/A
OCF(TTM)7.3
OCFY31.14%
SpS26.78
BVpS28.04
TBVpS28.04
PEG (NY)0.81
PEG (5Y)1.13
Profitability
Industry RankSector Rank
ROA 2.69%
ROE 12.07%
ROCE 4.65%
ROIC 3.74%
ROICexc 3.83%
ROICexgc 3.83%
OM 20%
PM (TTM) 12.64%
GM 71.26%
FCFM N/A
ROA(3y)2.67%
ROA(5y)3.05%
ROE(3y)11.83%
ROE(5y)13.91%
ROIC(3y)3.46%
ROIC(5y)3.6%
ROICexc(3y)3.48%
ROICexc(5y)3.62%
ROICexgc(3y)3.48%
ROICexgc(5y)3.62%
ROCE(3y)4.31%
ROCE(5y)4.48%
ROICexcg growth 3Y1.52%
ROICexcg growth 5Y-2.23%
ROICexc growth 3Y1.52%
ROICexc growth 5Y-2.23%
OM growth 3Y8.16%
OM growth 5Y1.8%
PM growth 3Y-10.44%
PM growth 5Y5.87%
GM growth 3Y3.22%
GM growth 5Y2.04%
F-Score3
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 2.02
Debt/FCF N/A
Debt/EBITDA 5.93
Cap/Depr 259.44%
Cap/Sales 40.45%
Interest Coverage 250
Cash Conversion 76.62%
Profit Quality N/A
Current Ratio 1
Quick Ratio 0.77
Altman-Z 0.58
F-Score3
WACC5.24%
ROIC/WACC0.71
Cap/Depr(3y)219.4%
Cap/Depr(5y)213.13%
Cap/Sales(3y)33.34%
Cap/Sales(5y)32.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.56%
EPS 3Y5.55%
EPS 5Y6.05%
EPS Q2Q%7.58%
EPS Next Y8.4%
EPS Next 2Y7.91%
EPS Next 3Y7.87%
EPS Next 5Y7.6%
Revenue 1Y (TTM)8.25%
Revenue growth 3Y0.84%
Revenue growth 5Y1.89%
Sales Q2Q%14.37%
Revenue Next Year2.73%
Revenue Next 2Y3.36%
Revenue Next 3Y3.58%
Revenue Next 5Y4.67%
EBIT growth 1Y16.84%
EBIT growth 3Y9.07%
EBIT growth 5Y3.72%
EBIT Next Year94.38%
EBIT Next 3Y32.6%
EBIT Next 5Y22.84%
FCF growth 1Y-8.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y45.64%
OCF growth 3Y9.22%
OCF growth 5Y5.77%